LOW vs ZYME · P/E 18, rev $86.29B vs rev $76.3M
Lowe's Companies Inc (LOW) versus Zymeworks Inc. Common Stock (ZYME) — a side-by-side from cached financials, not a winner call.
Lowe's Companies Inc (LOW) is a home improvement retail company listed on NYSE.
Zymeworks Inc. Common Stock (ZYME) is a biotechnology company listed on NASDAQ.
Latest reported LOW revenue for 2026-01-30 was $86.29B. Net income was $6.65B. Revenue was up 3.1% from 2025-01-31 to 2026-01-30. LOW currently screens at market cap $121.89B and trailing P/E 18.4.
Latest reported ZYME revenue for 2024-12-31 was $76.3M. Net income was -$122.7M. Revenue was up 0.4% from 2023-12-31 to 2024-12-31. ZYME currently screens at market cap $1.68B.
LOW currently screens at market cap $121.89B and trailing P/E 18.4. ZYME currently screens at market cap $1.68B.
Not investment advice. Open the LOW and ZYME stock pages for the full models.
Not investment advice.